By Caroline Helwick  / November 10, 2024  / 2024 International Myeloma Society Annual Meeting

Evolving Role of MRD Status in Multiple Myeloma

The use of measurable (or minimal) residual disease (MRD) status to guide treatment in multiple myeloma has become a topic of intense interest. Phase III studies presented at the Plenary Session of th...